Article PDF
Literatur
Uijen AA, van de Lisdonk EH. Multimorbidity in primary care: prevalence and trend over the last 20 years. Eur J Gen Pract, 14(Suppl 1): 28–32, 2008
Gosch M. Polypharmazie: Pharmakotherapie mit Qualität MMA Geriatrie Praxis 01/2008
Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients – a metaanalysis of prospective studies. JAMA, 279: 1200–1205, 1998
Ebbesen J, Buajordet I, Erikssen J, Brørs O, Hilberg T, Svaar H, Sandvik L. Drug-related deaths in department of internal medicine. Arch Intern Med, 161: 2317–2323, 2001
Schnurrer JU, Frölich JC. Incidence and prevention of lethal undesirable drug effects. Internist (Berl), 44: 889–895, 2003
Hanlon JT, Schmader KE, Koronkowski KJ, et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc, 45: 945–948, 1997
Colley CA, Lucas LM. Polypharmacy: the cure becomes the disease. J Gen Intern Med, 8: 278–283, 1993
Chester M, Chen L, Kaski JC. Identification of patients at high risk for adverse coronary events while waiting routine coronary angioplasty. Br Heart J, 73: 216–222, 1995
Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med, 161: 2712–2716, 2003
Côté I, Farris K, Olson K, et al. Assessing the usefulness of the medication appropriateness index in a community setting. working paper 03.01; 2003. http://www.ihe.ca/documents/2003-01paper.pdf
Yazid K, Aichhorn W. Wilde Mischung mit ungewissen Folgen, Polypharmazie im höheren Lebensalter. Ärzte Woche 22/6, 2008
Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin Ther, 6: 592–599, 1984
Kuijpers MA, van Marum RJ, Egberts AC, Jansen PA. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol, 65: 130–133, 2007
Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahoney D. STOPP (Screening tool of older person's prescriptions) and START (Screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharm Thera, 66: 72–83, 2008
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gosch, M., Roller, R. Polypharmazie – eine neue Herausforderung in einer alternden Gesellschaft. Wien Med Wochenschr 160, 261–263 (2010). https://doi.org/10.1007/s10354-010-0783-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10354-010-0783-4